Today, more people die of lung cancer than from any other forms
of cancer combined. However, little significant improvement has
been made on how to cure this disease in advanced stage.
Unfortunately, the majority of lung cancer patients are
diagnosed with advanced disease. Mayo Clinic researchers
discovered that some inherited factors could influence the
course of lung cancer, including response to treatment, disease
progression, development of new cancer, survival and quality of
life of the patients. Over the past decade, thousands of lung
cancer patients and their relatives have taken part in our lung
cancer studies, enabled clinicians and researchers to carry out
long-term, in-depth studies of disease etiology and patient
outcome. Our basic aims are to find people who are at high risk
of developing lung cancer through better understanding of how
genes or traits can be easily tested to guide treatment for each
patient, and to improve survival and quality of life among lung
cancer patients. While our purpose